Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis

por Zarate, R, Rodríguez, J, Bandres, E, Patiño-Garcia, A, Ponz-Sarvise, M, Viudez, A, Ramirez, N, Bitarte, N, Chopitea, A, Gacía-Foncillas, J
Publicado 2010

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)

por González-Flores, E., Serrano, R., Sevilla, I., Viúdez, A., Barriuso, J., Benavent, M., Capdevila, J., Jimenez-Fonseca, P., López, C., Garcia-Carbonero, R.
Publicado 2018

Stellate cells, a point of light in the dark night of pancreatic cancer

por Ramírez, N, Viúdez, A, Hernández-García, I, Guerrero, D, Gómez-Dorronsoro, M, Herrera, F J, Vila, J, Beloki, L, Ciaúrriz, M, Mansilla, C, Vera, R
Publicado 2014

Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin

por Capdevila, J., Hernando, J., Teule, A., Lopez, C., Garcia-Carbonero, R., Benavent, M., Custodio, A., Garcia-Alvarez, A., Cubillo, A., Alonso, V., Carmona-Bayonas, A., Alonso-Gordoa, T., Crespo, G., Jimenez-Fonseca, P., Blanco, M., Viudez, A., La Casta, A., Sevilla, I., Segura, A., Llanos, M., Landolfi, S., Nuciforo, P., Manzano, J. L.
Publicado 2023

Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of tra...

por Custodio, A, Carmona-Bayonas, A, Jiménez-Fonseca, P, Sánchez, M L, Viudez, A, Hernández, R, Cano, J M, Echavarria, I, Pericay, C, Mangas, M, Visa, L, Buxo, E, García, T, Rodríguez Palomo, A, Álvarez Manceñido, F, Lacalle, A, Macias, I, Azkarate, A, Ramchandani, A, Fernández Montes, A, López, C, Longo, F, Sánchez Bayona, R, Limón, M L, Díaz-Serrano, A, Hurtado, A, Madero, R, Gómez, C, Gallego, J
Publicado 2017